Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 405–406 | Cite as

Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy

  • Qian-Nan Jia
  • Giang Huong Nguyen
  • Kai Fang
  • Hong-Zhong Jin
  • Yue-Ping ZengEmail author
Correspondence
  • 8 Downloads

References

  1. 1.
    Kutlubay Z, Engin B, Zara T, Tuzun Y. Anogenital malignancies and premalignancies:facts and controversies. Clin Dermatol 2013; 31: 362–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Morton C, Szeimies RM, Sidoroff A, et al. European Dermatology Forum Guidelines on topical photodynamic therapy. Eur J Dermatol 2015; 25: 296–311.PubMedGoogle Scholar
  3. 3.
    Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre–cancer using topical ALA–PDT–a single hospital experience. Photodiagnosis Photodyn Ther 2008; 5: 127–33.CrossRefPubMedGoogle Scholar
  5. 5.
    Feldmeyer L, Krausz–Enderlin V, Tondury B, Hafner J, French LE, Hofbauer GF. Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat. Dermatology 2011; 223: 52–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Varma S, Holt PJ, Anstey AV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy:a cautionary tale. Br J Dermatol 2000; 142: 825–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Park JY, Kim SJ, Kim YC. Erythroplasia of Queyrat refractory to photodynamic therapy. Clin Exp Dermatol 2012; 37: 795–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Arlette JP, Trotter MJ. Squamous cell carcinoma in situ of the skin:history, presentation, biology and treatment. Australas J Dermatol 2004; 45: 1–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Evangelou G, Farrar MD, Cotterell L, et al. Topical photodynamic therapy significantly reduces epidermal Langerhans cells during clinical treatment of basal cell carcinoma. Br J Dermatol 2012; 166: 1112–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Morton CA. The emerging role of 5–ALA–PDT in dermatology:is PDT superior to standard treatments? J Dermatolog Treat 2002;13:S25–9.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Qian-Nan Jia
    • 1
  • Giang Huong Nguyen
    • 2
  • Kai Fang
    • 1
  • Hong-Zhong Jin
    • 1
  • Yue-Ping Zeng
    • 1
    Email author
  1. 1.Department of Dermatology, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  2. 2.Department of DermatologyUniversity of Colorado Anschutz Medical CampusAuroraUSA

Personalised recommendations